21 completed, 3 unknown, 2 terminated. 15 Phase 2, 8 Phase 3, 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 15 | Completed 12, Terminated 2, Unknown 1 |
| Phase 3 | 8 | Completed 6, Terminated 1, Unknown 1 |
| Phase 1 | 4 | Completed 4 |
Follow Hemangiopericytoma, Malignant: new trials by email Literature Review of Hemangiopericytoma, Malignant trials Research Report on Hemangiopericytoma, Malignant
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma doxorubicin hydrochloride, trabectedin, laboratory biomarker analysis - Sarcoma | Phase 2 / Phase 3 | Terminated | European Organisation for Research and Treatment of Cancer - EORTC | 133 | 2011-05-01 | 2014-08-08 |
| Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Stage IB, Stage II, or Stage III Soft Tissue Sarcoma gene expression analysis, polymerase chain reaction, western blotting - Sarcoma | Phase 2 | Terminated | City of Hope Medical Center | 1 | 2008-07-01 | 2014-07-11 |
| Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma Cixutumumab, Doxorubicin Hydrochloride, Laboratory Biomarker Analysis - Adult Angiosarcoma, Adult Desmoplastic Small Round Cell Tumor | Phase 1 | Completed | National Cancer Institute (NCI) | 30 | 2008-06-01 | 2016-05-17 |
| Tissue Sample Collection From Patients With Soft Tissue Sarcoma of the Arms, Hands, Legs, or Feet Treated on Clinial Trial CRUK-VORTEX microarray analysis, molecular diagnostic method, biologic sample preservation procedure - Sarcoma | Unknown | The Christie NHS Foundation Trust | 400 | 2007-08-01 | 2013-08-26 | |
| Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer bevacizumab, placebo, magnetic resonance imaging - Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma | Phase 2 | Completed | National Cancer Institute (NCI) | 11 | 2007-06-01 | 2014-05-09 |
| Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas sunitinib malate - Adult Malignant Fibrous Histiocytoma of Bone, Desmoid Tumor | Phase 2 | Completed | Memorial Sloan Kettering Cancer Center | 53 | 2007-04-01 | 2016-01-20 |
| Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma doxorubicin hydrochloride, clinical observation, therapeutic conventional surgery - Adult Alveolar Soft-part Sarcoma, Adult Angiosarcoma | Phase 3 | Completed | Children's Oncology Group | 588 | 2007-02-05 | 2022-04-28 |
| Vatalanib in Treating Patients With Recurrent or Progressive Meningioma vatalanib - Brain and Central Nervous System Tumors, Sarcoma | Phase 2 | Completed | Northwestern University | 25 | 2006-05-01 | 2018-10-26 |
| Randomised Trial of Volume of Post-operative Radiotherapy Given to Adult Patients With eXtremity Soft Tissue Sarcoma radiotherapy - Sarcoma | Phase 3 | Completed | Sheffield Teaching Hospitals NHS Foundation Trust | 216 | 2006-03-01 | 2021-03-18 |
| Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma doxorubicin hydrochloride, ifosfamide, adjuvant therapy - Childhood Malignant Fibrous Histiocytoma of Bone, Sarcoma | Phase 3 | Unknown | European Paediatric Soft Tissue Sarcoma Study Group | 250 | 2006-03-01 | 2013-08-12 |
| S0505 Sorafenib in Treating Patients With Advanced Soft Tissue Sarcomas sorafenib - Sarcoma | Phase 2 | Completed | National Cancer Institute (NCI) | 51 | 2006-03-01 | 2014-05-15 |
| Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma romidepsin - Adult Alveolar Soft-part Sarcoma, Adult Angiosarcoma | Phase 2 | Completed | National Cancer Institute (NCI) | 40 | 2005-01-07 | 2017-06-14 |
| Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or Foot That Has Been Removed by Surgery celecoxib, adjuvant therapy, radiation therapy - Childhood Malignant Fibrous Histiocytoma of Bone, Sarcoma | Phase 1 | Completed | University of Miami | 3 | 2004-03-01 | 2016-12-15 |
| Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma perifosine - Endometrial Cancer, Sarcoma | Phase 2 | Completed | NCIC Clinical Trials Group | 17 | 2003-06-09 | 2023-08-04 |
| Soblidotin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma soblidotin - Sarcoma | Phase 2 | Completed | Daiichi Sankyo | 2003-04-01 | 2012-05-16 | |
| Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma brostallicin - Gastrointestinal Stromal Tumor, Sarcoma | Phase 2 | Completed | European Organisation for Research and Treatment of Cancer - EORTC | 64 | 2002-05-01 | 2012-07-18 |
| Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma exatecan mesylate - Sarcoma | Phase 2 | Completed | European Organisation for Research and Treatment of Cancer - EORTC | 39 | 2002-05-01 | 2012-07-18 |
| Liposomal Doxorubicin Plus Ifosfamide in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma ifosfamide, pegylated liposomal doxorubicin hydrochloride - Sarcoma | Phase 1 | Completed | European Organisation for Research and Treatment of Cancer - EORTC | 28 | 2001-11-01 | 2012-09-24 |
| STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma imatinib mesylate - Endometrial Cancer, Gastrointestinal Stromal Tumor | Phase 1 / Phase 2 | Completed | European Organisation for Research and Treatment of Cancer - EORTC | 91 | 2000-08-01 | 2012-09-24 |
| Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors dactinomycin, filgrastim, carboplatin - Ovarian Cancer, Sarcoma | Phase 2 | Completed | Societe Internationale d'Oncologie Pediatrique | 1998-11-01 | 2013-12-04 |
Showing 20 of 26. Sign in to see all of them.
Sarcoma (25) · Fibrosarcoma (23) · Hemangiosarcoma (23) · Liposarcoma (22) · Histiocytoma, Malignant Fibrous (20) · Leiomyosarcoma (20) · Neurofibrosarcoma (19) · Sarcoma, Synovial (19) · Malignant mesenchymal tumor (16) · Rhabdomyosarcoma (14) · Sarcoma, Alveolar Soft Part (12) · Chondrosarcoma, Extraskeletal Myxoid (9) · Endometrial Neoplasms (7) · Ovarian Neoplasms (7)
Neoplasms by Histologic Type (26) · Neoplasms (25) · Neoplasms, Connective and Soft Tissue (25) · Neoplasms, Vascular Tissue (25) · Neoplasms, Connective Tissue (23) · Neoplasms, Fibrous Tissue (23) · Neoplasms, Nerve Tissue (23) · Neoplasms, Adipose Tissue (22) · Neoplasms, Muscle Tissue (21) · Nervous System Diseases (21) · Nervous System Neoplasms (21) · Histiocytoma (20) · Nerve Sheath Neoplasms (19) · Neurofibroma (19) · Neuromuscular Diseases (19)
Doxorubicin (8) · Ifosfamide (8) · Radiotherapy (6) · Chemotherapy, Adjuvant (4) · Filgrastim (3) · Neoadjuvant Therapy (3) · Carboplatin (2) · Cyclophosphamide (2) · Dactinomycin (2) · Epirubicin (2) · Etoposide (2) · Trabectedin (2) · Vincristine (2) · Bevacizumab (1) · Blotting, Western (1)
European Organisation for Research and Treatment of Cancer - EORTC (9) · National Cancer Institute (NCI) (4) · Societe Internationale d'Oncologie Pediatrique (2) · Children's Oncology Group (1) · City of Hope Medical Center (1) · Daiichi Sankyo (1) · European Paediatric Soft Tissue Sarcoma Study Group (1) · Herbert Irving Comprehensive Cancer Center (1) · Memorial Sloan Kettering Cancer Center (1) · NCIC Clinical Trials Group (1) · Northwestern University (1) · Sheffield Teaching Hospitals NHS Foundation Trust (1) · The Christie NHS Foundation Trust (1) · University of Miami (1)
United States (11) · United Kingdom (10) · Belgium (7) · Denmark (7) · France (7) · Germany (6) · Netherlands (5) · Slovakia (4) · Spain (4) · Austria (3) · Canada (3) · Switzerland (3) · Hungary (2) · Ireland (2) · Poland (2)
A.N. Van Geel, MD (1) · Aaron H. Wolfson, MD (1) · Andrea Ferrari, MD (1) · Annabel B.M. Foot (1) · Axel Le Cesne, MD (1) · Bernadette Brennan, MD (1) · Catherine West (1) · Christophe Bergeron (1) · Elizabeth A. Eisenhauer, MD (1) · George D. Demetri, MD (1) · Heather P. McDowell, MD (1) · Jacob Verweij, MD, PhD (1) · James E. Butrynski, MD (1) · Jeffrey J. Raizer, MD (1) · Joern Treuner, MD (1)
PMID 11705489, PMID 12528778, PMID 12957454, PMID 15010069, PMID 15177491, PMID 15592836, PMID 15659504, PMID 16528479, PMID 17095209, PMID 17109446, PMID 17336054, PMID 17634494, PMID 19088049, PMID 19451429, PMID 20338746, PMID 22665534, PMID 22954508, PMID 25858498, PMID 28391003, PMID 30954717, PMID 31786124, PMID 33548339, PMID 34623899, PMID 36566574, PMID 38757485, PMID 39122389, PMID 41386267
2009 (1), N01CM00071 (1), N01CM62202 (1), P30CA008748 (1), P30CA012197 (1), P30CA014599 (1), P30CA016672 (1), P30CA033572 (1), U10CA032102 (1), U10CA081851 (1), U10CA098543 (1)